Jove
Visualize
Contact Us

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduction of red blood cell transfusion with a patient blood management protocol in urological and visceral surgery: a before-after study.

Anaesthesia, critical care & pain medicine·2024
Same author

Early postoperative bleeding after isolated coronary bypasses: Changes over a period of 20 years - An observational study.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2021
Same author

Prevalence of antithrombotic use in a vitreoretinal surgery cohort.

Journal francais d'ophtalmologie·2021
Same author

Integrating a pharmacist into an anaesthesiology and critical care department: Is this worthwhile?

International journal of clinical pharmacy·2019
Same author

Multicentre, prospective, double-blind, randomised controlled clinical trial comparing different non-opioid analgesic combinations with morphine for postoperative analgesia: the OCTOPUS study.

British journal of anaesthesia·2019
Same author

Bleeding complications following peripheral regional anaesthesia in patients treated with anticoagulants or antiplatelet agents: A systematic review.

Anaesthesia, critical care & pain medicine·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 26, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

[Summary and perspectives. Rivaroxaban].

P Albaladejo1

  • 1Pôle d'Anesthésie Réanimation, CHU de Grenoble, BP217, 38043 Grenoble cedex 9, France. ludovic.drouet@lrb.ap-hop-paris.fr

Annales Francaises D'Anesthesie Et De Reanimation
|February 3, 2009
PubMed
Summary

New oral anticoagulants offer a convenient oral route for managing venous thromboembolism (VTE). Rivaroxaban shows superior efficacy over enoxaparin in preventing VTE after major orthopedic surgery.

Area of Science:

  • Pharmacology
  • Thrombosis
  • Orthopedic Surgery

Context:

  • Venous thromboembolism (VTE) management is evolving with new therapeutic options.
  • Major orthopedic surgeries (total hip and knee replacements) carry a significant risk of VTE.
  • Current anticoagulation strategies require improvement for specific patient populations.

Purpose:

  • To review the clinical implications of new oral anticoagulants (NOACs) in VTE management.
  • To compare the efficacy and safety of rivaroxaban with enoxaparin for VTE prophylaxis post-orthopedic surgery.
  • To highlight the need for optimized NOAC use in high-risk patients.

Summary:

  • New oral anticoagulants (NOACs) are poised to transform venous thromboembolism (VTE) treatment, primarily due to their oral administration.

Related Experiment Videos

Last Updated: Jun 26, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

  • Rivaroxaban demonstrates enhanced efficacy compared to enoxaparin in preventing thromboembolic events following total hip and total knee replacement surgeries.
  • Phase III studies indicate an acceptable safety profile for NOACs, heralding a new era in VTE prophylaxis.
  • Impact:

    • The advent of NOACs signifies a paradigm shift in VTE prophylaxis, offering improved patient convenience.
    • Further research is necessary to refine the management of VTE in patients with renal impairment, obesity, or advanced age.
    • Optimizing NOAC therapy in high-risk groups is crucial to mitigate thrombotic and hemorrhagic risks.